Skip to main content
Top
Published in: Abdominal Radiology 1/2015

01-01-2015

Comparative study of MRI manifestations of acute and chronic Budd–Chiari syndrome

Authors: Delei Cheng, Hao Xu, Rong Hua, Kai Xu, Weifei Lv, Xin Lu, Hongtao Du, Qingqiao Zhang

Published in: Abdominal Radiology | Issue 1/2015

Login to get access

Abstract

Background

Magnetic resonance imaging (MRI) is able to diagnose Budd–Chiari syndrome (BCS) by distinguishing differential imaging features of acute and chronic forms of the disease. However, the characteristic imaging differences are still not clear as previous data were mostly obtained from scattered small samples instead of large comparative study.

Aim

To investigate MRI manifestations of acute and chronic (BCS), and to evaluate the value of MRI for diagnosis of acute and chronic BCS.

Methods and results

We retrospectively compared MRI results of 24 patients with acute and 82 patients with chronic BCS using Mann–Whitney U test for ascites volume, and Fisher’s exact test for intrahepatic venous collaterals and extra-hepatic venous collaterals. In the acute group, MRI findings suggested thrombosis in hepatic vein (HV) in all acute patients and additional inferior vena cava (IVC) thrombosis in 5 patients. In the chronic BCS group, 6 and 15 patients showed solitary obstruction either in the IVC or HV, respectively, while 61 patients showed combined IVC and HV obstruction. More patients with acute BCS presented with ascites accompanied with high signals on T2WI from intravenous obstructive lesions. Further, the average maximal spleen diameter in patients with acute BCS, and the ratio of patients with acute BCS developing intrahepatic venous collaterals and extra-hepatic venous collaterals were also lower compared with chronic BCS. All these differences were statistically significant.

Conclusion

MRI indicates direct and indirect features of BCS, and therefore enables accurate diagnosis of acute and chronic BCS.
Literature
1.
go back to reference Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. (2009) Etiology, management, and outcome of the Budd–Chiari syndrome. Ann Intern Med 151:167–175PubMedCrossRef Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. (2009) Etiology, management, and outcome of the Budd–Chiari syndrome. Ann Intern Med 151:167–175PubMedCrossRef
4.
go back to reference Singh V, Sinha SK, Nain CK, et al. (2000) Budd–Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol 15:550–554PubMedCrossRef Singh V, Sinha SK, Nain CK, et al. (2000) Budd–Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol 15:550–554PubMedCrossRef
5.
go back to reference Darwish Murad S, Valla DC, de Groen PC, et al. (2004) Determinants of survival and the effect of portosystemic shunting in patients with Budd–Chiari syndrome. Hepatology 39:500–508PubMedCrossRef Darwish Murad S, Valla DC, de Groen PC, et al. (2004) Determinants of survival and the effect of portosystemic shunting in patients with Budd–Chiari syndrome. Hepatology 39:500–508PubMedCrossRef
6.
go back to reference Rajani R, Melin T, Björnsson E, et al. (2009) Budd–Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival—an 18-year experience. Liver Int 29:253–259PubMedCrossRef Rajani R, Melin T, Björnsson E, et al. (2009) Budd–Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival—an 18-year experience. Liver Int 29:253–259PubMedCrossRef
7.
go back to reference Shrestha SM, Okuda K, Uchida T, et al. (1996) Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 11:170–179PubMedCrossRef Shrestha SM, Okuda K, Uchida T, et al. (1996) Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 11:170–179PubMedCrossRef
8.
go back to reference Okuda H, Yamagata H, Obata H, et al. (1995) Epidemiological and clinical features of Budd–Chiari syndrome in Japan. J Hepatol 22:1–9PubMedCrossRef Okuda H, Yamagata H, Obata H, et al. (1995) Epidemiological and clinical features of Budd–Chiari syndrome in Japan. J Hepatol 22:1–9PubMedCrossRef
9.
go back to reference Cheng D, Xu H, Lu ZJ, et al. (2013) Clinical features and etiology of Budd–Chiari syndrome in Chinese patients: a single-center study. J Gastroenterol Hepatol 28:1061–1067PubMedCrossRef Cheng D, Xu H, Lu ZJ, et al. (2013) Clinical features and etiology of Budd–Chiari syndrome in Chinese patients: a single-center study. J Gastroenterol Hepatol 28:1061–1067PubMedCrossRef
10.
go back to reference Lupescu IG, Dobromir C, Popa GA, Gheorghe L, Georgescu SA (2008) Spiral computed tomography and magnetic resonance angiography evaluation in Budd–Chiari syndrome. J Gastrointestin Liver Dis 17:223–226PubMed Lupescu IG, Dobromir C, Popa GA, Gheorghe L, Georgescu SA (2008) Spiral computed tomography and magnetic resonance angiography evaluation in Budd–Chiari syndrome. J Gastrointestin Liver Dis 17:223–226PubMed
11.
go back to reference Noone TC, Semelka RC, Siegelman ES, et al. (2000) Budd–Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging. J Magn Reson Imaging 11:44–50PubMedCrossRef Noone TC, Semelka RC, Siegelman ES, et al. (2000) Budd–Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging. J Magn Reson Imaging 11:44–50PubMedCrossRef
12.
go back to reference Soyer P, Rabenandrasana A, Barge J, et al. (1994) MRI of Budd–Chiari syndrome. Abdom Imaging 19:325–329PubMed Soyer P, Rabenandrasana A, Barge J, et al. (1994) MRI of Budd–Chiari syndrome. Abdom Imaging 19:325–329PubMed
13.
14.
go back to reference Li L-S (2007) Comment on definition and classification of Budd–Chiari syndrome. J Intervent Radiol 16:75–78 ((in Chinese)) Li L-S (2007) Comment on definition and classification of Budd–Chiari syndrome. J Intervent Radiol 16:75–78 ((in Chinese))
15.
go back to reference Mo Y-F, Zhang X-L, Zhang L-J, Li X-L, Hu B-S (2007) MRI of portal vein and superior mesenteric veilons thrombosis with intestinal ischemia. Chin J Radiol 41:180–183 ((in Chinese)) Mo Y-F, Zhang X-L, Zhang L-J, Li X-L, Hu B-S (2007) MRI of portal vein and superior mesenteric veilons thrombosis with intestinal ischemia. Chin J Radiol 41:180–183 ((in Chinese))
16.
go back to reference Erden A, Erden I, Karayalçin S, Yurdaydin C (2002) Budd–Chiari syndrome: evaluation with multiphase contrast-enhanced three-dimensional MR angiography. AJR Am J Roentgenol 179:1287–1292PubMedCrossRef Erden A, Erden I, Karayalçin S, Yurdaydin C (2002) Budd–Chiari syndrome: evaluation with multiphase contrast-enhanced three-dimensional MR angiography. AJR Am J Roentgenol 179:1287–1292PubMedCrossRef
17.
go back to reference Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R (2002) Large regenerative nodules in Budd–Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR Am J Roentgenol 178:877–883PubMedCrossRef Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R (2002) Large regenerative nodules in Budd–Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR Am J Roentgenol 178:877–883PubMedCrossRef
18.
go back to reference Valla DC (2003) The diagnosis and management of the Budd–Chiari syndrome: consensus and controversies. Hepatology 38:793–803PubMedCrossRef Valla DC (2003) The diagnosis and management of the Budd–Chiari syndrome: consensus and controversies. Hepatology 38:793–803PubMedCrossRef
19.
go back to reference Buckley O, O’ Brien J, Snow A, et al. (2007) Imaging of Budd–Chiari syndrome. Eur Radiol 17:2071–2078PubMedCrossRef Buckley O, O’ Brien J, Snow A, et al. (2007) Imaging of Budd–Chiari syndrome. Eur Radiol 17:2071–2078PubMedCrossRef
20.
go back to reference Langlet P, Escolano S, Valla DC, et al. (2003) Clinicopathological forms and prognostic index in Budd–Chiari syndrome. J Hepatol 39:496–501PubMedCrossRef Langlet P, Escolano S, Valla DC, et al. (2003) Clinicopathological forms and prognostic index in Budd–Chiari syndrome. J Hepatol 39:496–501PubMedCrossRef
21.
go back to reference Noone TC, Semelka RC, Woosley JT, et al. (1996) Ultrasound and MRI findings in acute Budd–Chiari syndrome with histopathologic correlation. J Comput Assist Tomogr 20:819–822PubMedCrossRef Noone TC, Semelka RC, Woosley JT, et al. (1996) Ultrasound and MRI findings in acute Budd–Chiari syndrome with histopathologic correlation. J Comput Assist Tomogr 20:819–822PubMedCrossRef
22.
go back to reference Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd–Chiari syndrome: imaging features. Radiology 210:443–450PubMedCrossRef Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd–Chiari syndrome: imaging features. Radiology 210:443–450PubMedCrossRef
23.
go back to reference Flor N, Zuin M, Brovelli F, et al. (2010) Regenerative nodules in patients with chronic Budd–Chiari syndrome: a longitudinal study using multiphase contrast-enhanced multidetector CT. Eur J Radiol 73:588–593PubMedCrossRef Flor N, Zuin M, Brovelli F, et al. (2010) Regenerative nodules in patients with chronic Budd–Chiari syndrome: a longitudinal study using multiphase contrast-enhanced multidetector CT. Eur J Radiol 73:588–593PubMedCrossRef
Metadata
Title
Comparative study of MRI manifestations of acute and chronic Budd–Chiari syndrome
Authors
Delei Cheng
Hao Xu
Rong Hua
Kai Xu
Weifei Lv
Xin Lu
Hongtao Du
Qingqiao Zhang
Publication date
01-01-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 1/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0193-y

Other articles of this Issue 1/2015

Abdominal Radiology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.